
Lineage Updates COR1 Cell Therapy Program for Corneal Disease
Lineage Cell Therapeutics Advances COR1 Program to Develop Off-the-Shelf Cell Therapy for Corneal Endothelial Disease Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company focused on developing allogeneic, off-the-shelf cell therapies…












